Luna is the world's smallest iCGM-compatible insulin patch pump with a first-of-its-kind fully closed-loop algorithm designed to make automated insulin delivery easier, lower cost, and accessible to ...

Researchers conducted a large-scale epidemiological study to explore the potential health benefits of high muscle strength in preventing type 2 diabetes (T2D) across varying levels of genetic risk ...

The research findings advance the understanding of how impaired mitochondrial dynamics and quality control may contribute to skeletal muscle insulin resistance and the manifestation of T2D, and ...

Between 2006 and 2021, Sweden saw a dramatic rise in early-onset type 2 diabetes (T2D), with the prevalence more than doubling from 0.27% to 0.64% and incidence nearly doubling from 54 to 107 per ...

A cross-sectional analysis from Yale School of Medicine estimates that approximately 5.8 million adolescents and 11.1 million ...

For example, Tarumi et al implemented an EHR-integrated system to predict HbA 1C changes associated with various treatment options for T2D, effectively showcasing the practicality of AI-based ...

Age-standardized mortality rates following ischemic HF were higher in patients with T2D than in those without diabetes (19.2 vs 15.1 and 20.4 vs 16.5 per 100 person-years in women and men ...

"Luna Health secures $23.6m for insulin patch pump development" was originally created and published by Medical Device ...

Tandem Diabetes Care announced that the FDA cleared the company's next-generation automated insulin delivery (AID) algorithm, Control-IQ+, for adults with type 2 diabetes (T2D).